openPR Logo
Press release

Preimplantation Genetic Testing Market Top Scenario, SWOT Analysis, Business Overview & Forecast 2027

03-05-2020 08:55 AM CET | Health & Medicine

Press release from: Allied Market Research

Preimplantation Genetic Testing Market

Preimplantation Genetic Testing Market

According to a new report published by Allied Market Research, titled, "Preimplantation Genetic Testing Market by Product (Reagents & Consumables and Instruments), by Procedure (Preimplantation Genetic Screening and Preimplantation Genetic Diagnosis), by Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization, Comparative Genomic Hybridization, and Single-Nucleotide Polymorphism), and by Application (Aneuploidy, Single Gene Disorder, Structural Chromosomal Abnormalities, X-Linked Disorders, Human Leukocyte Typing and Gender Identification) - Global Opportunity Analysis and Industry Forecast, 2020-2027".

The global market size of Preimplantation Genetic Testing market is $XX million in 2019 with XX CAGR, and it is expected to reach $XX million by the end of 2027 with a CAGR of XX% from 2020 to 2027.

Click Here To Access Free Sample Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/3784

The key players of the market included in the report are Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Coopersurgical, Inc., Abbott Laboratories, Natera, Inc., Oxford Gene Technology, Yikon Genomics, and SciGene Corporation.

Key Benefits

o The study provides an in-depth analysis of the global preimplantation genetic testing market, with current trends and future estimations to elucidate imminent investment pockets.
o It presents a quantitative analysis from 2016 to 2023 to enable stakeholders to capitalize on prevailing market opportunities.
o Extensive analysis of the market by product elucidates various forms of available preimplantation genetic testing methods.
o Key players have been profiled and their strategies thoroughly analyzed, which predict the competitive outlook of the market.
o By region, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/3784

Preimplantation Genetic Testing Market Key Segmentation:

By Product

o Reagents & Consumables
o Instruments

By Procedure

o Preimplantation Genetic Screening
o Preimplantation Genetic Diagnosis

By Technology

o Next-Generation Sequencing
o Polymerase Chain Reaction
o Fluorescence in Situ Hybridization
o Comparative Genomic Hybridization
o Single-Nucleotide Polymorphism

By Application

o Aneuploidy
o Single Gene Disorder
o Structural Chromosomal Abnormalities
o Translocations
o Deletions
o Duplications
o Inversions
o X-Linked Disorders
o Human Leukocyte Typing
o Gender Identification.

By Region

o North America
o U.S.
o Canada
o Mexico
o Europe
o Germany
o UK
o France
o Spain
o Italy
o Rest of Europe
o Asia-Pacific
o Japan
o China
o India
o Australia
o Rest of Asia-Pacific
o LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Argentina
o Rest of LAMEA

Obtain Report Details: https://www.alliedmarketresearch.com/preimplantation-genetic-testing-market

Similar Reports:

Intraoperative Neuromonitoring Market: https://www.prnewswire.com/news-releases/intraoperative-neuromonitoring-market-expected-to-reach-4900-million-globally-by-2022---allied-market-research-616239004.html

Respiratory Care Devices Market: https://www.prnewswire.com/news-releases/global-respiratory-care-devices-market-expected-to-reach-21300-million-by-2022---allied-market-research-613591163.html

Anesthesia Devices Market: https://www.medgadget.com/2018/12/anesthesia-devices-market-analysis-of-the-global-industry-helps-to-understand-business-intelligence-practices.html

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Market Pulse: https://blog.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Preimplantation Genetic Testing Market Top Scenario, SWOT Analysis, Business Overview & Forecast 2027 here

News-ID: 1955656 • Views: 278

More Releases from Allied Market Research

Diphtheria, Tetanus, and Pertussis (DTP) Vaccine Market Expected to Reach $7.05 …
According to a new report published by Allied Market Research, titled, “Diphtheria, Tetanus, and Pertussis (DTP) Vaccine Market by Product, Age Group, and End User: Opportunity Analysis and Industry Forecast, 2020–2027," the global Diphtheria, Tetanus, and Pertussis Vaccine market was valued at $ 4,758.8 million in 2019 and is expected to reach $ 7,054.4 million by 2027, with a CAGR of 5.1% from 2020-2027. The DTaP segment accounted for major
Burn Care Market Expected to Reach $3,134 Million by 2027
According to a new report published by Allied Market Research, titled, “Burn care Market by Product, Depth of Burn, and End User: Opportunity Analysis and Industry Forecast, 2020–2027," the global burn care market size was valued at $1,992 million in 2019, and is projected to reach $3,134 million by 2027, growing at a CAGR of 5.6% from 2020 to 2027. Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/4395 Burns are injuries
Drug Delivery Devices Market projected to Cross $26.7 Billion by 2026
Drug Delivery Devices Market size was valued at $19 billion in 2018, and is expected to reach $26.7 billion by 2026, registering a CAGR of 4.3% from 2019 to 2026. Drugs are used to improve health and to extend lives. However, the medications can be taken in various ways, including by swallowing, by absorption, by inhalation, through the skin, and by intravenous injection. For this, the drug delivery devices are developed,
Pharmaceutical Filtration Market on Position to Hit $7.74 Billion by 2026
Pharmaceutical filtration is defined as a filtration process to separate suspended particles from a medium or solution by passing them through a membrane. They reduce or eliminate the bacteria or other microorganisms in process components. The filtration process can be combined with other pharmaceutical manufacturing operations. Pharmaceutical filters are used in the production of small molecule ingredients such as active pharmaceutical ingredients (APIs) and pharmaceutical excipients. In addition, it is

All 5 Releases


More Releases for Gene

Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies. In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
Gene Synthesis Market Size 2017-2022 OriGene, Gene Oracle, Genescript
e Global Gene Synthesis Market Research Report 2016 is a professional and in-depth study on the current state of the Gene Synthesis market. Annual estimates and forecasts are provided for the period 2017 through 2022. Also, a six-year historic analysis is provided for these markets. The Global market for Gene Synthesis is expected to reach about 410 million USD by 2022 from 200 million USD in 2017, registering a compounded
Gene Therapy Drug Pipeline Analysis
“Gene Therapy Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Gene Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight
Cancer Gene Therapy Market Analysis
The gene therapy market has undergone series of transformation from the initial days of research to current clinical development of drugs for treatment of multiple diseases. The initial studies of gene therapy were conducted mostly on monogenetic diseases, but the focus of the researchers rapidly shifted towards the cancer. The increasing popularity of cancer therapeutics as a major interest for gene therapy applications led to it accounting for a dominant
Global Gene Editing Technologies Market
Gene editing with engineered nucleases is anticipated to contribute significantly to the global life sciences industry. Gene editing provides application from studying gene functions in plants and animals to gene therapy in humans. Gene editing has more efficiency than many other methods in reverse genetics. Increased development of genetic engineering and increased funding in the field of gene editing is anticipated to drive the growth of the global gene editing